Details

Autor(en) / Beteiligte

• Cetnar, Alexander D.
• Tomov, Martin L.
• Ning, Liqun
• Jing, Bowen
• Theus, Andrea S.
• Kumar, Akaash
• Wijntjes, Amanda N.
• Bhamidipati, Sai Raviteja
• Do, Katherine Pham
• Mantalaris, Athanasios
• Oshinski, John N.
• Avazmohammadi, Reza
• Lindsey, Brooks D.
• Bauser‐Heaton, Holly D.
• Serpooshan, Vahid

Titel

Patient‐Specific 3D Bioprinted Models of Developing Human Heart

Ist Teil von

• Advanced healthcare materials, 2021-08, Vol.10 (15), p.e2001169-n/a

Ort / Verlag

Germany: Wiley Subscription Services, Inc

Erscheinungsjahr

2021

Quelle

Wiley-Blackwell Journals

Beschreibungen/Notizen

• The heart is the first organ to develop in the human embryo through a series of complex chronological processes, many of which critically rely on the interplay between cells and the dynamic microenvironment. Tight spatiotemporal regulation of these interactions is key in heart development and diseases. Due to suboptimal experimental models, however, little is known about the role of microenvironmental cues in the heart development. This study investigates the use of 3D bioprinting and perfusion bioreactor technologies to create bioartificial constructs that can serve as high‐fidelity models of the developing human heart. Bioprinted hydrogel‐based, anatomically accurate models of the human embryonic heart tube (e‐HT, day 22) and fetal left ventricle (f‐LV, week 33) are perfused and analyzed both computationally and experimentally using ultrasound and magnetic resonance imaging. Results demonstrate comparable flow hemodynamic patterns within the 3D space. We demonstrate endothelial cell growth and function within the bioprinted e‐HT and f‐LV constructs, which varied significantly in varying cardiac geometries and flow. This study introduces the first generation of anatomically accurate, 3D functional models of developing human heart. This platform enables precise tuning of microenvironmental factors, such as flow and geometry, thus allowing the study of normal developmental processes and underlying diseases. 3D bioprinting enables manufacturing of live patient‐specific models of the human heart at different stages of development. Embryonic and fetal human heart analogs can be bioprinted, cellularized, perfused via bioreactors, and analyzed using a variety of experimental and computational tools to examine the cellular response to perturbations in flow hemodynamics and geometry.